Higher Odds of Adverse Cutaneous Reactions in Patients With Dermatomyositis Treated With Hydroxychloroquine Compared With Methotrexate

Higher Odds of Adverse Cutaneous Reactions in Patients With Dermatomyositis Treated With Hydroxychloroquine Compared With Methotrexate

Objective Hydroxychloroquine (HCQ) use for the treatment of dermatomyositis (DM) has been associated with adverse cutaneous reactions. We applied a new user, active comparator, retrospective design to assess differences in adverse cutaneous reactions or hospitalizations between HCQ and methotrexate...

Full description

Bibliographic Details
Main Authors: Astia Allenzara, Alison Hollis, Carolina Álvarez, Haejin Lovelace, Steve Maczuga, Matthew Helm, Nancy Olsen, Amanda Nelson, Galen Foulke
Format: Article
Language:English
Published: Wiley 2023-11-01
Series:ACR Open Rheumatology
Online Access:https://doi.org/10.1002/acr2.11605

Similar Items

Similar Items